Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9315811 Methods for modulating kallikrein (KLKB1) expression

Patent 9315811 was granted and assigned to Ionis Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 24 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11840686 Modulation of prekallikrein (PKK) expression
0
Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+500 characters)
Article

Patent abstract

Disclosed herein are methods for decreasing kallikrein and treating or preventing inflammatory conditions in an individual in need thereof. Examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to kallikrein include hereditary angioedema (HAE). Methods for inhibiting kallikrein can also be used as a prophylactic treatment to prevent individuals at risk for developing an inflammatory condition, such as, hereditary angioedema.

Edits on 29 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 29 Sep, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Alexey Revenko0
Gourab Bhattacharjee0
Robert A. MacLeod0
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093158110
Edits on 24 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09315811 Methods for modulating kallikrein (KLKB1) expression US Patent 9315811 Methods for modulating kallikrein (KLKB1) expression

Infobox
Patent Number
093158110
Patent Number
93158110
Edits on 26 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
093158110
Date of Patent
April 19, 2016
0
Patent Application Number
141246300
Date Filed
June 8, 2012
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093158110
Patent Primary Examiner
‌
Sean McGarry
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09315811
Edits on 6 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 6 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09315811 Methods for modulating kallikrein (KLKB1) expression

Infobox
Is a
Patent
Patent
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09315811
Date of patent
April 19, 2016
Patent application number
14124630
Date Filed
June 8, 2012
Patent primary examiner
‌
Sean McGarry

Find more entities like US Patent 9315811 Methods for modulating kallikrein (KLKB1) expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo